PharmaShots | Incisive News in 3 Shots

Subscribe Now

Footprints

Samsung Bioepis Expand its Footprints with the Launch of Hadlima (biosimilar- adalimumab) in Australia and Canada

Samsung Bioepis Expand its Footprints with the Launch of Hadlima (biosimilar- adalimumab) in Australia and Canada

March 30, 2021

MHLW Approves Novartis' Five New Therapies Expanding its Footprints in Japan

MHLW Approves Novartis' Five New Therapies Expanding its Footprints in Japan

June 29, 2020

Amgen Signs an Agreement with BeiGene for the Expansion of its Oncology Footprints in China

Amgen Signs an Agreement with BeiGene for the Expansion of its Oncology Footprints in China

January 3, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us